PTC Therapeutics, Inc. Restricted Stock Agreement Granted Under 2013 Stock Incentive PlanRestricted Stock Agreement • May 16th, 2013 • PTC Therapeutics, Inc. • Pharmaceutical preparations • Delaware
AGREEMENT FOR THE PROVISION OF FUNDING TO PTC THERAPEUTICS, INC. FOR RESEARCH RELATING TO SELECTIVELY DECREASING THE PRODUCTION OF BMI-1 EXPRESSION IN TUMOUR STEM CELLSAgreement • May 16th, 2013 • PTC Therapeutics, Inc. • Pharmaceutical preparations • England
AGREEMENT FOR THE PROVISION OF FUNDING TO PTC THERAPEUTICS, INC. FOR RESEARCH RELATING TO THE LEAD OPTIMISATION AND DEVELOPMENT OF NOVEL BACTERIAL DNA SYNTHESIS INHIBITORS FOR THE TREATMENT OF NOSOCOMIAL INFECTIONS CAUSED BY MULTI-DRUG RESISTANT...Agreement • May 16th, 2013 • PTC Therapeutics, Inc. • Pharmaceutical preparations • England
PTC Therapeutics, Inc. Nonstatutory Stock Option Agreement Granted Under 2013 Stock Incentive PlanNonstatutory Stock Option Agreement • May 16th, 2013 • PTC Therapeutics, Inc. • Pharmaceutical preparations
PTC THERAPEUTICS, INC. SECOND AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT Dated as of March 7, 2013Rights Agreement • May 16th, 2013 • PTC Therapeutics, Inc. • Pharmaceutical preparations • Delaware
THIS SECOND AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT, is entered into as of March 7, 2013 (this “Agreement”), among PTC THERAPEUTICS, INC., a Delaware corporation (the “Company”), and each of the investors listed on Schedule A and Schedule B hereto (each of which is referred to in this Agreement as an “Investor”).
LOAN AND SECURITY AGREEMENTLoan Modification Agreement • May 16th, 2013 • PTC Therapeutics, Inc. • Pharmaceutical preparations • New York
THIS LOAN AND SECURITY AGREEMENT (this “Agreement”) dated as of September 21, 2009 (the “Effective Date”) among OXFORD FINANCE CORPORATION, a Delaware corporation with an office located at 133 North Fairfax Street, Alexandria, Virginia 22314 (“Oxford”), as collateral agent (“Collateral Agent”), the Lenders listed on Schedule 1.1 hereof and otherwise party hereto from time to time (each a “Lender” and collectively, the “Lenders”), and PTC THERAPEUTICS, INC., a Delaware corporation (“Borrower”), provides the terms on which Lenders shall lend to Borrower and Borrower shall repay Lenders. The parties agree as follows:
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. License and Collaboration AgreementLicense and Collaboration Agreement • May 16th, 2013 • PTC Therapeutics, Inc. • Pharmaceutical preparations • Delaware
WHEREAS, PTC has discovered proprietary compounds that are potentially useful for the treatment of spinal muscular atrophy and possesses proprietary technology and intellectual property rights relating thereto; and
PTC Therapeutics, Inc. Restricted Stock Agreement Granted Under 2009 Equity and Long Term Incentive PlanRestricted Stock Agreement • May 16th, 2013 • PTC Therapeutics, Inc. • Pharmaceutical preparations • Delaware
